146 related articles for article (PubMed ID: 19151765)
1. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer.
Yang SL; Cao Q; Zhou KC; Feng YJ; Wang YZ
Oncogene; 2009 Mar; 28(10):1320-8. PubMed ID: 19151765
[TBL] [Abstract][Full Text] [Related]
2. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer.
Shi Y; Ding X; He ZH; Zhou KC; Wang Q; Wang YZ
Gut; 2009 Nov; 58(11):1443-50. PubMed ID: 19651628
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential canonical type 3 channels and blood pressure in humans.
Thilo F; Baumunk D; Krause H; Schrader M; Miller K; Loddenkemper C; Zakrzewicz A; Krueger K; Zidek W; Tepel M
J Hypertens; 2009 Jun; 27(6):1217-23. PubMed ID: 19417689
[TBL] [Abstract][Full Text] [Related]
4. Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway.
Louhivuori LM; Jansson L; Nordström T; Bart G; Näsman J; Akerman KE
Cell Calcium; 2010; 48(2-3):114-23. PubMed ID: 20728215
[TBL] [Abstract][Full Text] [Related]
5. The Na+/Ca2+ exchange inhibitor KB-R7943 potently blocks TRPC channels.
Kraft R
Biochem Biophys Res Commun; 2007 Sep; 361(1):230-6. PubMed ID: 17658472
[TBL] [Abstract][Full Text] [Related]
6. Ca2+ mobilization mediated by transient receptor potential canonical 3 is associated with thrombin-induced morphological changes in 1321N1 human astrocytoma cells.
Nakao K; Shirakawa H; Sugishita A; Matsutani I; Niidome T; Nakagawa T; Kaneko S
J Neurosci Res; 2008 Sep; 86(12):2722-32. PubMed ID: 18478545
[TBL] [Abstract][Full Text] [Related]
7. TRPM4b channel suppresses store-operated Ca2+ entry by a novel protein-protein interaction with the TRPC3 channel.
Park JY; Hwang EM; Yarishkin O; Seo JH; Kim E; Yoo J; Yi GS; Kim DG; Park N; Ha CM; La JH; Kang D; Han J; Oh U; Hong SG
Biochem Biophys Res Commun; 2008 Apr; 368(3):677-83. PubMed ID: 18262493
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of histamine H2 receptors activates TRPC3 channels through both phospholipase C and phospholipase D.
Kwan HY; Wong CO; Chen ZY; Dominic Chan TW; Huang Y; Yao X
Eur J Pharmacol; 2009 Jan; 602(2-3):181-7. PubMed ID: 19032951
[TBL] [Abstract][Full Text] [Related]
9. FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.
Tao X; Zhao N; Jin H; Zhang Z; Liu Y; Wu J; Bast RC; Yu Y; Feng Y
Endocr Relat Cancer; 2013 Jun; 20(3):415-29. PubMed ID: 23580589
[TBL] [Abstract][Full Text] [Related]
10. Expression of transient receptor potential (TRP) channels in human and murine osteoblast-like cells.
Abed E; Labelle D; Martineau C; Loghin A; Moreau R
Mol Membr Biol; 2009 Apr; 26(3):146-58. PubMed ID: 19115145
[TBL] [Abstract][Full Text] [Related]
11. TRPC3: a multifunctional, pore-forming signalling molecule.
Eder P; Poteser M; Groschner K
Handb Exp Pharmacol; 2007; (179):77-92. PubMed ID: 17217051
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent expression of transient receptor potential canonical type 3 channels in patients with chronic kidney disease.
Liu Y; Krueger K; Hovsepian A; Tepel M; Thilo F
Arch Biochem Biophys; 2011 Oct; 514(1-2):44-9. PubMed ID: 21802402
[TBL] [Abstract][Full Text] [Related]
14. Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells.
Cai R; Ding X; Zhou K; Shi Y; Ge R; Ren G; Jin Y; Wang Y
Int J Cancer; 2009 Nov; 125(10):2281-7. PubMed ID: 19610066
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
17. TRPC1 regulates skeletal myoblast migration and differentiation.
Louis M; Zanou N; Van Schoor M; Gailly P
J Cell Sci; 2008 Dec; 121(Pt 23):3951-9. PubMed ID: 19001499
[TBL] [Abstract][Full Text] [Related]
18. Analysis of TRPC3-interacting proteins by tandem mass spectrometry.
Lockwich T; Pant J; Makusky A; Jankowska-Stephens E; Kowalak JA; Markey SP; Ambudkar IS
J Proteome Res; 2008 Mar; 7(3):979-89. PubMed ID: 18205297
[TBL] [Abstract][Full Text] [Related]
19. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity.
Huang L; Li B; Li W; Guo H; Zou F
Carcinogenesis; 2009 May; 30(5):737-44. PubMed ID: 19176641
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
